FMR LLC & Abigail Johnson Hold 7.064% Stake in ARGENX SE
Ticker: ARGX · Form: SC 13G/A · Filed: Feb 9, 2024 · CIK: 1697862
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, biotechnology, stake-holding
TL;DR
**FMR LLC and Abigail Johnson still own over 7% of ARGENX SE, signaling continued institutional interest.**
AI Summary
FMR LLC, a major investment firm, and its CEO, Abigail P. Johnson, have updated their ownership in ARGENX SE, a biological products company. As of February 9, 2024, they collectively beneficially own 4,173,842 shares, representing 7.064% of ARGENX SE's common stock. This filing, an amendment to a previous one, indicates a significant, but not controlling, stake held by a prominent institutional investor, which can signal confidence in the company's long-term prospects to current and potential shareholders.
Why It Matters
This filing shows that a major institutional investor, FMR LLC, and its leader, Abigail P. Johnson, maintain a substantial stake in ARGENX SE, which can be seen as a vote of confidence in the company's future by a sophisticated market participant.
Risk Assessment
Risk Level: low — This filing indicates stable institutional ownership, which generally reduces perceived risk for a company.
Analyst Insight
Investors should note the continued significant institutional ownership by FMR LLC, which can be a positive signal, but should also conduct their own due diligence on ARGENX SE's fundamentals and future prospects.
Key Numbers
- 4,173,842 — Shares Beneficially Owned (Total common stock shares of ARGENX SE owned by FMR LLC and Abigail P. Johnson)
- 7.064% — Percent of Class (Percentage of ARGENX SE's common stock beneficially owned by FMR LLC and Abigail P. Johnson)
- N0610Q109 — CUSIP Number (Identifier for ARGENX SE's common stock)
- 20240209 — Filed As Of Date (The date this SC 13G/A amendment was filed)
Key Players & Entities
- FMR LLC (company) — reporting person and parent holding company
- Abigail P. Johnson (person) — reporting person, likely CEO of FMR LLC
- ARGENX SE (company) — the issuer of the securities
- 0001697862 (company) — Central Index Key (CIK) for ARGENX SE
- 0000315066 (company) — Central Index Key (CIK) for FMR LLC
Forward-Looking Statements
- FMR LLC will maintain a significant stake in ARGENX SE, indicating continued long-term investment interest. (ARGENX SE) — medium confidence, target: 2025-02-09
FAQ
Who are the primary reporting persons in this SC 13G/A filing for ARGENX SE?
The primary reporting persons are FMR LLC and Abigail P. Johnson, as stated in Item 1 of the filing.
What percentage of ARGENX SE's common stock do FMR LLC and Abigail P. Johnson collectively beneficially own?
They collectively beneficially own 7.064% of ARGENX SE's common stock, as indicated in Item 11 for both reporting persons and Item 4(b) for FMR LLC.
How many shares of ARGENX SE common stock are beneficially owned by FMR LLC and Abigail P. Johnson?
Both FMR LLC and Abigail P. Johnson are reported to beneficially own 4,173,842 shares of ARGENX SE common stock, according to Item 7 for both and Item 4(a) for FMR LLC.
What is the business address of the filer, FMR LLC?
The business address of FMR LLC is 245 Summer Street, Boston, Massachusetts 02210, as specified in Item 2(b) of the filing.
Under which rule is this Schedule 13G/A filed?
This Schedule 13G/A is filed pursuant to Rule 13d-1(b), as indicated by the checked box in the filing and further explained in Item 3.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 9, 2024 by Abigail P. Johnson regarding ARGENX SE (ARGX).